Search Results 41-50 of 16076 for Non-Hodgkin+lymphoma
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) Rochester, ...
Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · Share · Facebook · Twitter.
... lymphoma has come back after completion of initial chemotherapy treatment for their aggressive B-cell Non-Hodgkin lymphoma. The purpose of the study is to ...
Lenalidomide may stop the growth of non-Hodgkin lymphoma by blocking blood flow to the cancer. Giving lenalidomide together with rituximab and bendamustine ...
... lymphoma (Cheson, 2014) non-Hodgkin lymphoma (B-NHL) subgroups. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
ANSWER: Lymphomas are cancers of the immune system. They are broadly classified into Hodgkin lymphoma and non-Hodgkin lymphoma. Each of those categories ...
It is not yet known whether combination chemotherapy together with rituximab is more effective in treating patients with non-Hodgkin lymphoma or B-cell acute ...
Clinical Trials · Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone ...
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma · Share · Facebook · Twitter.
Learn more about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.